Sign in
Explore the registryTrack Ifinatamab deruxtecan's trials

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Ifinatamab DeruxtecanOngoingRecruitingPhase 1Open NCT07630974 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…